ARCHIVES

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

This article is from The Cancer Letter archive.

Vol. 20 No. 26 | July 1, 1994

Download PDF Visit The Full Archive

Related Articles

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011

Organ Systems Move, Other Directory Changes

July 7, 1989

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

Appeals Court Lifts Injunction On Federal Funding for Stem Cell Research.

September 10, 2010